Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SZSE: 300452)
Health Care · Pharmaceuticals · CN
CN¥12.77
-1.39% today · -10.6% 1Y
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SZSE: 300452) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $441.91M and employs 1,130 people.
Over the last twelve months the share price has lost 10.6%, trading between 11.12 and 17.14.
Tweenvest scores Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. across four factors: quality 88/100, value 78/100, growth 70/100, dividend 64/100. Its strongest factor is quality.
300452 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $441.91M
- Revenue (TTM)
- $146.27M
- P/E
- 17.25
- EPS
- 0.74
- Dividend yield
- 2.35%
- Beta (5Y)
- 0.20
- 52-week high
- CN¥17.14
- 52-week low
- CN¥11.12
- Avg volume (3M)
- —
- Shares outstanding
- 232.63M
- Employees
- 1,130
- Next earnings
- —
About Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
Headquartered in Huainan, China, Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. operates within China as a manufacturer and seller of pharmaceutical excipients and specialized medicines. The company's diverse offerings include cellulose, starch, povidone, stearic acid, coating powders, resins, and food additives. Furthermore, it exports these products internationally to regions such as Europe, the United States, and Southeast Asia.
- ISIN
- CNE100001ZH5
- Founded
- 2001
- Listed since
- May 15, 2015
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.